Literature DB >> 31943407

On the Aqueous Chemistry of the UIV -DOTA Complex.

Gev Dovrat1, Marie-Claire Illy2, Claude Berthon2, Ana Lerner3,4, Moshe H Mintz1,4, Eric Maimon5,4, Radion Vainer5, Yeshayahu Ben-Eliyahu4, Yulia Moiseev4, Philippe Moisy2, Armand Bettelheim6, Israel Zilbermann5,4.   

Abstract

The 1,4,7,10-tetrazacyclodecane-1,4,7,10-tetraacetic acid (DOTA) aqueous complex of UIV with H2 O, OH- , and F- as axial ligands was studied by using UV/Vis spectrophotometry, ESI-MS, NMR spectroscopy, X-ray crystallography, and electrochemistry. The UIV -DOTA complex with either water or fluoride as axial ligands was found to be inert to oxidation by molecular oxygen, whereas the complex with hydroxide as an axial ligand slowly hydrolyzed and was oxidized by dioxygen to a diuranate precipitate. The combined data set acquired shows that, although axial substitution of fluoride and hydroxide ligands instead of water does not seem to significantly change the aqueous DOTA complex structure, it has an important effect on the electronic configuration of the complex. The UIV /UIII redox couple was found to be quasi-reversible for the complex with both axially bonded H2 O and hydroxide, but irreversible for the complex with axially bonded fluoride. Intriguingly, binding of the axial fluoride renders the irreversible one-electron UV /UIV oxidation of the [UIV (DOTA)(H2 O)] complex quasi-reversible, which suggests the formation of the short-lived pentavalent form of the complex, an aqueous non-uranyl chelated UV cation.
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  electrochemistry; ligand effects; redox chemistry; structure elucidation; uranium

Year:  2020        PMID: 31943407     DOI: 10.1002/chem.201905357

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  4 in total

1.  Stable Chelation of the Uranyl Ion by Acyclic Hexadentate Ligands: Potential Applications for 230U Targeted α-Therapy.

Authors:  Joshua J Woods; Ryan Unnerstall; Abbie Hasson; Diane S Abou; Valery Radchenko; Daniel L J Thorek; Justin J Wilson
Journal:  Inorg Chem       Date:  2022-02-09       Impact factor: 5.436

2.  Theoretical Study of Actinide(III)-DOTA Complexes.

Authors:  Attila Kovács
Journal:  ACS Omega       Date:  2021-05-11

3.  Harnessing α-Emitting Radionuclides for Therapy: Radiolabeling Method Review.

Authors:  Hua Yang; Justin J Wilson; Chris Orvig; Yawen Li; D Scott Wilbur; Caterina F Ramogida; Valery Radchenko; Paul Schaffer
Journal:  J Nucl Med       Date:  2021-09-09       Impact factor: 11.082

4.  Facile transmetallation of [SbIII(DOTA)]- renders it unsuitable for medical applications.

Authors:  Catherine Chen; Charlotte Sommer; Helge Thisgaard; Vickie McKee; Christine J McKenzie
Journal:  RSC Adv       Date:  2022-02-16       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.